FDA Clearance Tracker · P930016-S010
VISX STAR S2 AND S3 EXCIMER LASER SYSTEM
Last checked: Nov 20, 2026Latest source record: Oct 18, 2000 (this decision)Source: openFDAMethods & limitations
Decided
Oct 18, 2000
Approved
Time to decision
488 days
Received Jun 18, 1999. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Panel Track
Device class
Class III
The decision
- FDA number
- P930016-S010
- Device name
- VISX STAR S2 AND S3 EXCIMER LASER SYSTEM
- Applicant
- Amo Manufacturing USA, LLC
- Applicant location
- Milpitas, CA
- Received
- Jun 18, 1999
- Decided
- Oct 18, 2000
- Decision
- Approved
- Supplement type
- Panel Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Expedited review
- Yes, flagged as expedited in FDA's record.
- Original approval
- P930016
Device type
- Device type
- Excimer laser system (LZS)
- Device class
- Class III
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
THESE DEVICES ARE INDICATED FOR PHOTOREFRACTIVE KERATECTOMY (PRK) TREATMENTS: IN PATIENTS WITH DOCUMENTED EVIDENCE OF A CHANGE IN MANIFEST REFRACTION OF LESS THAN OR EQUAL TO 0.5 D PER YEAR FOR AT LEAST ONE YEAR PRIOR TO THE DATE OF PRE-OPERATIVE EXAMINATION; ANDIN PATIENTS 21 YEARS OF AGE OR OLDER FOR THE REDUCTION OR ELIMINATION OF NATURALLY OCCURRING HYPEROPIA BETWEEN +0.5 AND + 5.0 D SPHERE AT THE SPECTACLE PLANE WITH REFRACTIVE ASTIGMATISM FROM +0.5 TO +4.0 D WITH A MAXIMUM MANIFEST REFRACTION SPHERICAL EQUIVALENT (MRSE) OF +6.0 D.
Source documents
Other decisions for Amo Manufacturing USA, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K223838 · Decided Apr 12, 2023 · 111 days after receipt
Device type: Ophthalmic Femtosecond Laser (OOE) · Ophthalmology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.